Binimetinib in Addition to Standard Chemotherapy in KRAS Mutated NSCLC.

Clinical trial NCT02964689 · COMPLETED

Trial details

NCT number: NCT02964689
Sponsor: Swiss Cancer Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Non-small Cell Lung Cancer KRAS Gene Mutation Lung Cancer

Start date: 2017-04-12
Primary completion: 2021-07-02
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.